期刊文献+

P53在纯型卵巢内胚窦瘤中表达及其临床意义

Expression of P53 in pure ovarian yolk sac tumors and its clinical significance
下载PDF
导出
摘要 目的分析P53在卵巢内胚窦瘤的表达及临床意义。方法回顾性分析辽宁省肿瘤医院1984-2007年收治的64例纯型卵巢内胚窦瘤患者的临床病理资料,免疫组织化学法检测P53在卵巢内胚窦瘤中的表达,分析各因素对预后的影响。结果以铂类为基础的化疗方案,化疗疗程数>3个、残余瘤直径≤2 cm、腹水量≤100 ml是影响预后的独立因素。P53并不是影响预后的独立因素。结论以铂类为基础的化疗方案,化疗疗程数、残余瘤直径和腹水量是影响预后的独立因素。 Objective To investigate the P53 expression in ovarian germ sinus tumor and clinical significance. Methods We performed a review of 64 patients with pure ovarian YST from our department between 1984 and 2007,and the expression of P53 was investigated by immunochemistry. Results Patients with stage Ⅰ disease had a more favorable prognosis than those with stage Ⅲ and Ⅳ disease( P〈0. 01). Cisplatin based chemotherapy regimens gave better results than those without cisplatin( P〈0. 05). The difference in prognosis was significant in cases in which the size of residual tumor was 2 cm in diameter( P〈0. 01),in cases in which chemotherapy courses 3( P〈0. 05) and in cases in which ascites was either absent or 100 ml in volume( P〈0. 05),P53 status had no significant correlation with the prognosis in this study. Conclusion Ascites volume,chemotherapy courses and tumor-reductive surgery strongly affected the prognosis of this disease. Cisplatin based chemotherapy after surgery was superior to chemotherapy without cisplatin.
出处 《临床军医杂志》 CAS 2016年第1期26-29,共4页 Clinical Journal of Medical Officers
基金 辽宁省科技厅面上项目(2015020283)
关键词 预后因素 卵巢内胚窦瘤 P53 Prognostic factors Ovarian yolk sac tumors P53
  • 相关文献

参考文献9

  • 1Cancer Committee of the International Federation of Gynecology and Obstetrics Staging.Announcement:FIGO Cancer Committee[J].Gynecol Oncol,1989,25:383-385.
  • 2Eisenkop SM,Spirtos NM,Lin WCM.Optimal cytoreduction for advance epithelial ovarian cancer:a commentary[J].Gynecol Oncol,2006,103:329-335.
  • 3Nawa A,Obata N,Kikkawa F,et al.Prognostic factors of patients with yolk sac tumors of the ovary[J].Am Obstet Gynecol,2001,184(6):1182-1188.
  • 4Guo YL,Zhang YL,Zhu JQ.Prognostic value of serumα-fetoprotein in ovarian yolk sac tumors:a systematic review and meta-analysis[J].Mol Clin Oncol,2015,3(1):125-132.
  • 5Kojimahara T,Nakahara K,Takano T,et al.Yolk sac tumor of the ovary:a retrospective multicenter study of 33 Japanese women by Tohoku Gynecologic Cancer Unit(TGCU)[J].Tohoku J Exp Med,2013,230(4):211-217.
  • 6Cicin I,Saip P,Guney N,et al.Yolk sac tumours of the ovary:evaluation of clinicopathological features and prognostic factors[J].Eur J Obstet Gynecol Reprod Biol,2009,146(2):210-214.
  • 7Even C,LhomméC,Duvillard P,et al.Ovarian yolk sac tumour:general review[J].Bull Cancer,2011,98(8):963-975.
  • 8Lee CW1,Song MJ,Park ST,et al.Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors:a retrospective study of single institution[J].World J Surg Oncol,2011,9:123.
  • 9Williams SD.Malignant ovarian germ cell tumors//Gershenson DM,Mc Guire WP,Gore M,et al.Gynecologic cancer controversies in management[M].Philadelphia:Elsevier Churchill Livingstone,2004:499-502.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部